Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asthma Exacerbation Profile in Patients on Open Label Treatment With Benralizumab for Severe Eosinophilic Asthma - an Exploratory Cohort Study

NCT04102800 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.

NCT NCT04102800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asthma Exacerbation Profile in Patients on Open Label Treatment With Benralizumab for Severe Eosinophilic Asthma - an Exploratory Cohort Study
Lead sponsor
NHS Greater Glasgow and Clyde
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2019
Completion date
April 23, 2024
Enrollment
157 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

asthma